Cabenuva is now approved for dosing every two months.
Using the new dosing schedule, injectable cabotegravir and rilpivirine may only need to be administered six times a year. By Liz Highleyman On February 1, the Food and Drug Administration (FDA) approved a two-month dosing schedule for Cabenuva, the first complete HIV treatment regimen […]
Cabenuva now approved for dosing every two months Read More »










